122 related articles for article (PubMed ID: 3186727)
1. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
Rose C; Camus A; Schwartz JC
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8326-30. PubMed ID: 3186727
[TBL] [Abstract][Full Text] [Related]
2. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Rose C; Camus A; Schwartz JC
Neuroscience; 1989; 29(3):583-94. PubMed ID: 2739903
[TBL] [Abstract][Full Text] [Related]
3. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Camus A; Rose C; Schwartz JC
Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
[TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for the tripeptide Gly-Trp-Met, a major metabolite of endogenous cholecystokinin in brain.
Rose C; Vargas F; Bourgeat P; Schwartz JC
Neuropeptides; 1996 Jun; 30(3):231-5. PubMed ID: 8819147
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
Rose C; Vargas F; Silhouette B; Devaux B; Schwartz JC
Neuropeptides; 1995 Mar; 28(3):157-60. PubMed ID: 7791959
[TBL] [Abstract][Full Text] [Related]
6. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
Steardo L; Knight M; Tamminga CA; Chase TN
Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Law JK; Marabout B; Luthra PM; Moore AN; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2000 Feb; 43(4):664-74. PubMed ID: 10691692
[TBL] [Abstract][Full Text] [Related]
8. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
9. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
Warburton MJ; Bernardini F
Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
[TBL] [Abstract][Full Text] [Related]
10. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
Konkoy CS; Davis TP
J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of the C-terminal octapeptide of cholecystokinin by rat kidney membranes: characterization of the cleavage by solubilized endopeptidase-24.11.
Najdovski T; Collette N; Deschodt-Lanckman M
Life Sci; 1985 Sep; 37(9):827-34. PubMed ID: 3897758
[TBL] [Abstract][Full Text] [Related]
12. Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10).
Radu D; Tomkinson B; Zachrisson O; Weber G; de Belleroche J; Hirsch S; Lindefors N
Brain Res; 2006 Aug; 1104(1):175-82. PubMed ID: 16822484
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ganellin CR; Bishop PB; Bambal RB; Chan SM; Leblond B; Moore AN; Zhao L; Bourgeat P; Rose C; Vargas F; Schwartz JC
J Med Chem; 2005 Nov; 48(23):7333-42. PubMed ID: 16279793
[TBL] [Abstract][Full Text] [Related]
14. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.
Migaud M; Durieux C; Viereck J; Soroca-Lucas E; Fournié-Zaluski MC; Roques BP
Peptides; 1996; 17(4):601-7. PubMed ID: 8804068
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the role of "enkephalinase" in cholecystokinin inactivation.
Zuzel KA; Rose C; Schwartz JC
Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.
Lindén A; Carlquist M; Hansen S; Uvnäs-Moberg K
Gut; 1989 Feb; 30(2):213-22. PubMed ID: 2703143
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz JC
Neuroscience; 1999; 88(4):1225-40. PubMed ID: 10336132
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cholecystokinin metabolism by membrane preparations from the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
Medeiros Mdos S; Turner AJ
Neurochem Int; 1994 Apr; 24(4):369-77. PubMed ID: 7914787
[TBL] [Abstract][Full Text] [Related]
19. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
[TBL] [Abstract][Full Text] [Related]
20. Brain cholecystokinin-8 immunoreactivity in rats with experimental liver cirrhosis.
Salerno F; Bonato C; Panerai AE; Martini A; Malesci A
Life Sci; 1983 Jul; 33(4):377-81. PubMed ID: 6308371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]